acceptodds
Withdrawn from ICLR 2027

Beyond a Fixed Composite Endpoint: Guarded Orthogonal Learning for Preference-Robust Target-Group Audits

Withdrawn from ICLR 2027, so left out of the paper lists and the map.

Abstract

Clinical trials use a prespecified primary endpoint, yet downstream benefit–risk decisions often combine several outcomes and value trade-offs. We ask whether the treatment conclusion for a prespecified target group remains stable over an admissible utility class. We introduce PROBE, which learns reusable cross-fitted orthogonal effects for interpretable basis outcomes. We compare complete effect vectors under a utility-aware patient-level loss and use a held-out guard to adapt among zero, constant, shared, coordinate-specific, and private structures. The selected vector supports post-fit prediction, whereas confirmatory inference uses cross-fitted basis scores to construct direct multiplier max- bands over the prespecified group–utility family. These bands drive a four-way audit that returns robust support for either treatment, certified preference sensitivity, or evidence uncertainty. External preference information can then refine the admissible class without rerunning causal estimation. For this pipeline, we establish a uniform basis-approximation bound, an oracle inequality with an explicit exclusion price, false-admission control, asymptotic familywise validity, and an error bound combining causal and preference uncertainty. In prespecified raw-data simulations, PROBE admits complex structure in 50/50 strong private and 44/50 strong mixed runs, while all 100 null runs retain an anchor. Two 1,000-run reference experiments attain familywise coverage of 0.945 and 0.949. We then apply the causal audit to the IST randomized trial and analyze dependence-preserving preference evidence using 394 same-respondent part-worth vectors from a tuberculosis discrete-choice study. Together, these results show how PROBE supports transparent target-group auditing across clinically meaningful value trade-offs.

Primary area:
causal reasoning
Keywords:
causal inference, causal representation learning, heterogeneous treatment effects, multi-task learning, orthogonal learning, uncertainty quantification, decision making under uncertainty, composite outcomes

Reviews

Among:
Shape:
1234this paper, Bottom 2%
Figure 1. Mean review rating of the reviewed papers at ICLR 2027. This paper averages 1.33 over 3 reviews, above 2% of the others.
Reviewer_A1PKOpenReview ↗
Rating
2
Confidence
3
Informativeness
3
Presentation
2
Soundness
2
Read review
Paper summary

The paper studies whether a treatment conclusion for a prespecified target group remains stable across a clinically admissible family of utilities over multiple outcomes. PROBE learns reusable conditional-effect vectors for interpretable basis outcomes, uses held-out anchor-relative validation to select among shared and outcome-specific structures, and performs confirmatory inference by projecting cross-fitted orthogonal basis scores onto a frozen group-utility family with simultaneous multiplier max-t calibration. The resulting audit reports robust support for either treatment, certified preference sensitivity, or evidence uncertainty, and can incorporate external preference constraints without refitting the causal models. The framework is evaluated through extensive simulations, an IST aspirin audit, and a separate tuberculosis discrete-choice preference analysis.

Critical strengths

S1. The paper formulates a useful and interpretable inferential object: whether a target-group conclusion is stable over an admissible utility family, while distinguishing a genuine preference-dependent reversal from unresolved sampling uncertainty. The four-way abstaining output, explicit basis-approximation price, and modular preference refinement make the scope of each conclusion unusually transparent.

S2. The statistical workflow is careful and extensively validated. Learner construction, structure assembly, guarding, and inference are separated; confirmatory bands retain full cross-utility and cross-group covariance; false-decision control is stated for the frozen family; and the simulations examine selection, coverage, abstention, leverage, nuisance misspecification, high-dimensional scaling, and two-source uncertainty with clearly identified analysis units.

Critical weaknesses

W1. The paper does not establish the incremental necessity of guarded conditional-effect learning for its central confirmatory audit. Section 4.1 explicitly states that certification uses direct cross-fitted AIPW basis scores independently of the selected learner; thus, for prespecified target groups and utilities, a substantially simpler direct basis-score plus max-t procedure appears to produce the same four-way inferential output. The selected learner supports exploratory surfaces and subgroup construction, but the evaluation does not provide a matched end-to-end comparison showing that it improves the reported audit, and the distributional learners achieve lower predictive RMSE. This makes it unclear whether the main contribution is a new learning method or primarily a careful direct-inference wrapper.

W2. The real-data studies do not jointly validate the central outcome-preference pipeline. The IST analysis uses only three analyst-specified utility rows whose estimated effects have minimum pairwise correlation 0.9976, so it explores a narrow sensitivity family rather than empirical patient-preference heterogeneity. The tuberculosis DCE preserves respondent-level preference dependence, but its respondents are not linked to compatible trial outcomes, transport covariates are unavailable, and the intervals condition on deposited HB means rather than implementing the proposed preference-confidence region. The paper acknowledges these limitations, but they leave the full preference-robust causal audit supported only by simulation.

Questions for authors

Q1. For prespecified target groups and utilities, what audit decision, coverage, power, or efficiency gain is obtained from the selected guarded learner relative to a matched procedure that directly computes the same AIPW basis scores and max-t bands without fitting or selecting conditional-effect surfaces? Existing results for this comparison would directly affect the assessment of methodological necessity.

Q2. Which paper claims are intended to be validated by the IST and tuberculosis analyses separately, and which claims remain simulation-only because outcomes and preferences are not jointly observed? Please clarify whether the real-data evidence supports the complete PROBE pipeline or only its two component layers.

Q3. In the IST audit, are the three utility rows exact functions of the reported basis so that epsilon_u = 0, and what clinically plausible preference range is represented by three rows with minimum effect correlation 0.9976? A broader existing sensitivity result could materially change the assessment of practical informativeness.

Reviewer_ybxGOpenReview ↗
Rating
1
Confidence
3
Informativeness
1
Presentation
1
Soundness
1
Read review
Paper summary

The paper looks at the relationship between clinical trials, which typically have one pre-specified endpoint, and situations where there are classes of downstream evaluation metrics (or different utility functions, as denoted in this paper). The authors introduce a way to estimate how good a treatment is for different downstream utilities up to an additive term by linearizing utilities and deriving bounds for the accumulated error. The authors establish that this follows the proper coverage guarantee (e.g., an α\alpha guarantee), and show that this holds even in real-world healthcare RCTs.

Critical strengths

I think the space of downstream utilities in clinical trials is interesting, but I have a hard time understanding what this paper's contributions or problem statement is. I think with a better written paper, I could better assess the actual content of the paper, but as it stands now, it's hard for me to concretely point to strengths.

Critical weaknesses
  1. Presentation - The paper's presentation is quite hard to understand and parse. For example, it's unclear to me what the motivation is, what the repeated use of the words "audit" and "frozen set" mean, and just generally what much of the notation is. For example, just in the introduction, utility functions, c(ω)c(\omega), and preference robustness are all introduced without any explanation. As a result, the paper is very difficult to read, and even after spending considerable time on the paper, it's unclear what problem the paper is aiming to solve (I think they're trying to estimate downstream utilities) and what much of the wording means (e.g., what is "preference-robust target-group auditing"; what preferences are present here, who is the target-group, and why is the word auditing used here). Large parts of the paper are also relegated to the Appendix; while I understand that the nine page limit can be tight, it's still important to have an actual related works section, a meaningful discussion/conclusion, and readable tables of a reasonable size (e.g., Table 1). Later on in the paper, "library" is used for a set of coefficients, and I'm not sure what c(ω)c(\omega) represents even after reading through the full paper.
  2. Problem Assumptions - Even brushing aside presentation issues, the assumptions made by the paper are quite strong. While this isn't necessarily disqualifying by itself, these assumptions are rarely defended or even explained. For example, Assumption 2 is essentially assuming that the utility functions are approximately linear; why should we expect this to hold true? Similarly, why does it make sense to construct utility envelopes in the manner described at the bottom of page 3; each utility function is a different set of units (e.g., one might be in units related to fairness, others related to value, etc.), so why does it make sense to compare these. The beginning of Section 2.4 also introduces a new constraint set CtC_t added in step by step; it's unclear to me where this come from, or even what tt represents here.
Questions for authors
  1. What exactly is the motivation for this paper and what problem is it trying to solve
Reviewer_PyXSOpenReview ↗
Rating
1
Confidence
3
Informativeness
2
Presentation
1
Soundness
1
Read review
Paper summary

This paper proposes PROBE, a framework for auditing treatment effect conclusions across different utility functions with multiple outcomes. The motivating question is important: when a treatment affects multiple outcomes, treatment decisions may depend on heterogeneous individual preferences regarding these outcomes. How can we assess the robustness of treatment conclusions under different preferences?

Critical strengths

The paper raises an interesting and practically relevant question regarding treatment decisions under heterogeneous preferences.

Critical weaknesses
  1. Extremely poor exposition and lack of technical motivation. The paper introduces terms and notation without clear explanations. For example, Section 3 introduces four data partitions (construction, assembly, guarding, and inference) without clearly explaining the role of each partition and why the data are partitioned in this way. The authors also introduce the candidate learner g without explaining what it represents (from what I read later, I guess it is a mapping from X to the conditional expectation of the AIPW scores). Another example is the distinction between the anchor and adaptive departure sets. The authors define these sets but never explain why they are needed or why the candidates are separated in this particular way. This is not merely a presentation issue: the paper fails to communicate why its technical design is appropriate for the problem. The reader is left to guess the meanings and rationales behind the setup.

  2. The methodological framework is fundamentally disconnected. Section 3 develops an elaborate learning procedure to estimate conditional treatment-effect vectors from covariates. However, Section 4 conducts inference directly using AIPW scores, without using the learning algorithm from Section 3. Therefore, the main inference results do not require the learning procedure proposed in the paper. The authors fail to establish a meaningful connection between these two sections and demonstrate why the learning procedure is necessary. The paper reads more like a collection of largely independent techniques than a coherent paper.

  3. The main contribution is substantially underdeveloped. The central question is how to assess the robustness of treatment decisions under heterogeneous preferences, and the key to this problem is how to identify the set of plausible preferences. Once we know the set of preferences, estimating utility-weighted treatment effects and performing inference are relatively straightforward and standard. However, Section 4 focuses almost entirely on this latter step but says very little about how the candidate set of utility functions should be selected. Thus the paper provides little new insight into this problem.

Questions for authors

The manuscript requires substantial rewriting. I would recommend that the authors carefully proofread the paper before submission.

From OpenReview, CC BY 4.0. Authors as signed there; shown unedited.

Related papers

Discussion (0)

Sign in to comment.